SCHEMBL26913621

SCHEMBL26913621

Cc1ccc(S(=O)(=O)n2ccc3c(NC(=O)O)cc(Cl)c(F)c32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 4/20 0.41
▸ PPARD Q03181 4/20 0.41
▸ PPARA Q07869 4/20 0.41
▸ PDE4A P27815 2/20 0.41
▸ PDE4B Q07343 2/20 0.41
▸ PDE4C Q08493 2/20 0.41
▸ PDE4D Q08499 2/20 0.41
▸ MAPT P10636 1/20 0.37
▸ NPC1 O15118 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ RAPGEF4 Q8WZA2 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.36
▸ LMNA P02545 2/20 0.36
▸ GAA P10253 2/20 0.36
▸ HTT P42858 1/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ ALOX5 P09917 1/20 0.36
▸ PTGS2 P35354 1/20 0.36
▸ TSHR P16473 3/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26913270 0.89 PPARG (0.43) PPARGPPARDPPARAPDE4APDE4B
SCHEMBL26913617 0.87 MEN1 (0.38) PPARGPPARDPPARAPDE4APDE4B
SCHEMBL26912354 0.82 BRD4 (0.39) PDE4APDE4BPDE4CPDE4DRAPGEF4
SCHEMBL26913112 0.80 CA1 (0.40) PDE4APDE4BPDE4CPDE4DMAPT
SCHEMBL26914037 0.78 HTR6 (0.46) PPARGPPARDPPARAPDE4APDE4B
SCHEMBL26912756 0.76 MEN1 (0.39) PPARGPPARDPPARAPDE4APDE4B
SCHEMBL26913637 0.75 BRD4 (0.35) PDE4APDE4BPDE4CPDE4DRAPGEF4
SCHEMBL29031949 0.73 CA1 (0.41) MAPTRAPGEF4ALDH1A1GAAHTT
SCHEMBL26913079 0.72 BRD4 (0.36) PPARGPPARDPPARAPDE4APDE4B
SCHEMBL30684380 0.72 BRD4 (0.37) MAPTRAPGEF4ALDH1A1HTTBRD4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230391786-A1 cGAS INHIBITORS ELI LILLY AND COMPANY 2023-12-07 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230391786-A1 cGAS INHIBITORS CGAS, STING1, TBK1 PPARG 2031/4885PPARD 4183/4885PPARA 3995/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback